NC009 Clinical Trial
Sponsor: TB Alliance
Principal Investigator - Harriet Mayanja-Kizza, MBChB, MMed, PhD, Uganda-CWRU Research Collaboration
|
Type of Study / Description |
NC-009 pan-phase 2 clinical trial to evaluate the safety and efficacy of a combination of TBAJ-876, pretomanid and linezolid for its potential to shorten and improve treatment for both drug-sensitive and drug-resistant tuberculosis (TB) |
|
|
Interactions |
|
TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster acting and affordable tuberculosis drugs that are available to those who need them.
For further details about the TB Alliance and the NC-009 clinical trial, visit their website.